Next Article in Journal
A Placebo-Controlled, Double-Blind Randomized (Phase IIB) Trial of Oral Administration with HPV16 E7-Expressing Lactobacillus, GLBL101c, for the Treatment of Cervical Intraepithelial Neoplasia Grade 2 (CIN2)
Next Article in Special Issue
The COVID-19 Vaccine Is Here—Now Who Is Willing to Get It?
Previous Article in Journal
Interferon-Based Biopharmaceuticals: Overview on the Production, Purification, and Formulation
Previous Article in Special Issue
Demand Creation for COVID-19 Vaccination: Overcoming Vaccine Hesitancy through Social Marketing
Article

COVID-19 Vaccine Hesitancy among Young Adults in Saudi Arabia: A Cross-Sectional Web-Based Study

1
Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, P.O. Box 1882, Abha 61441, Saudi Arabia
2
Department of Pharmacognosy, College of Pharmacy, King Khalid University, P.O. Box 1882, Abha 61441, Saudi Arabia
3
Department of Pharmacology, College of Pharmacy, King Khalid University, P.O. Box 1882, Abha 61441, Saudi Arabia
*
Authors to whom correspondence should be addressed.
Academic Editor: Ralph J. DiClemente
Vaccines 2021, 9(4), 330; https://doi.org/10.3390/vaccines9040330
Received: 24 February 2021 / Revised: 23 March 2021 / Accepted: 25 March 2021 / Published: 1 April 2021
(This article belongs to the Special Issue Vaccination and Public Health Version II: COVID-19 Vaccination)
Ending the COVID-19 pandemic requires achieving herd immunity, either by previous infection or by vaccination. However, concerns about the COVID-19 vaccine are growing around the globe. The current study was conducted to investigate young the adult population’s hesitancy towards the vaccine. The study used a prospective cross-sectional design. Data was collected using an online self-administered questionnaire. A total of 862 Saudi adults participated. Information was gathered on the participants’ perspectives towards the severity and susceptibility of the COVID-19 infection, reasons for their hesitancy to receive the vaccine, perceived benefits, and reasons for action. Just under a quarter (19.6%) of respondents had previously tested positive for COVID-19. A small minority of the participants had already received the vaccine (2.1%), while 20.3% had registered in the Sehaty app (application) to receive the vaccine. Just under half of them (48%) will take the vaccine when mass vaccination is achieved and approximately the same number (46.7%) will only take it if it is made mandatory. Vaccine reluctance is highly prevalent among the general public in Saudi Arabia during the COVID-19 pandemic. While many are aware of a high likelihood of getting the infection, the efficacy and safety of the COVID-19 vaccine were reported as barriers to vaccination. View Full-Text
Keywords: vaccination hesitancy; Saudi Arbia; COVID-19; vaccine reluctance vaccination hesitancy; Saudi Arbia; COVID-19; vaccine reluctance
MDPI and ACS Style

Almaghaslah, D.; Alsayari, A.; Kandasamy, G.; Vasudevan, R. COVID-19 Vaccine Hesitancy among Young Adults in Saudi Arabia: A Cross-Sectional Web-Based Study. Vaccines 2021, 9, 330. https://doi.org/10.3390/vaccines9040330

AMA Style

Almaghaslah D, Alsayari A, Kandasamy G, Vasudevan R. COVID-19 Vaccine Hesitancy among Young Adults in Saudi Arabia: A Cross-Sectional Web-Based Study. Vaccines. 2021; 9(4):330. https://doi.org/10.3390/vaccines9040330

Chicago/Turabian Style

Almaghaslah, Dalia; Alsayari, Abdulrhman; Kandasamy, Geetha; Vasudevan, Rajalakshimi. 2021. "COVID-19 Vaccine Hesitancy among Young Adults in Saudi Arabia: A Cross-Sectional Web-Based Study" Vaccines 9, no. 4: 330. https://doi.org/10.3390/vaccines9040330

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop